Evaluation of reagin screen, a new serological test for syphilis.
AUTOR(ES)
Dyckman, J D
RESUMO
A total of 1,020 serum and plasma specimens were tested using the Venereal Disease Research Laboratory (VDRL), Rapid Plasma Reagin (RPR) card, Reagin Screen (RST) and Fluorescent Treponemal Antibody-Absorption (FTA-ABS) tests. In 257 normal patients, all screening tests were nonreactive; the FTA-ABS test was reactive for one patient. In 588 patients with treated and untreated syphilis, the RST results were 91.7% in agreement with the VDRL and RPR results. In 175 patients with diseases that cause biological false reactions, the RST was 94% in agreement with the other screening tests. The titer of the RST was within one dilution of the corresponding VDRL titer in 91.7% of the 360 speciments tested and within one dilution of the RPR titer in 96.9% of 358 specimens quantitated by both tests.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=274415Documentos Relacionados
- Evaluation of a new rapid plasma reagin card test as a screening test for syphilis.
- Evaluation of NCS rapid plasma reagin card test, a new screening kit for syphilis.
- Unheated serum reagin test as a quantitative test for syphilis.
- Qualitative evaluation of the reagin screen test.
- Comparison of CAPTIA syphilis G enzyme immunoassay with rapid plasma reagin test for detection of syphilis.
